Cas 307520-22-5,2(1H)-Pyridinone, 3-amino-6-methyl-4-(phenylmethoxy)-1-(phenylmethyl)-

307520-22-5

Post Buying Request

Basic information

Product Name: 2(1H)-Pyridinone, 3-amino-6-methyl-4-(phenylmethoxy)-1-(phenylmethyl)-
Synonyms:
CAS NO:307520-22-5
Molecular Formula: C20H20N2O2
Molecular Weight: 320.391
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2(1H)-Pyridinone, 3-amino-6-methyl-4-(phenylmethoxy)-1-(phenylmethyl)-(CAS DataBase Reference)
NIST Chemistry Reference: 2(1H)-Pyridinone, 3-amino-6-methyl-4-(phenylmethoxy)-1-(phenylmethyl)-(307520-22-5)
EPA Substance Registry System: 2(1H)-Pyridinone, 3-amino-6-methyl-4-(phenylmethoxy)-1-(phenylmethyl)-(307520-22-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 307520-22-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

307520-22-5 Suppliers

Recommended suppliers

307520-22-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 307520-22-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,7,5,2 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 307520-22:
(8*3)+(7*0)+(6*7)+(5*5)+(4*2)+(3*0)+(2*2)+(1*2)=105
105 % 10 = 5
So 307520-22-5 is a valid CAS Registry Number.

307520-22-5Upstream product

307520-21-4 C₂₀H₁₈N₂O₄

307520-22-5Downstream Products

307520-22-5Relevant academic research and scientific papers

Carboxylic acid derivatives that inhibit the binding of integrins to their receptors

-

Page 15; 33, (2010/11/30)

A method for the inhibition of the binding of α4β1 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which α4β1 is involved.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 307520-22-5